---
title: "Lantern Pharma (LTRN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/LTRN.US/norm.md"
symbol: "LTRN.US"
name: "Lantern Pharma"
parent: "https://longbridge.com/zh-CN/quote/LTRN.US.md"
datetime: "2026-05-19T15:34:35.291Z"
locales:
  - [en](https://longbridge.com/en/quote/LTRN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LTRN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LTRN.US/norm.md)
---

# Lantern Pharma (LTRN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3000 | -0.3600 | -0.3856 | -0.4016 | -0.4207 |
| ROE | -266.87% | -202.18% | -151.16% | -118.26% | -95.60% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -3.33M | -4.07M | -4.18M | -4.33M | -4.54M |
| 营业利润 | -3.41M | -4.20M | -4.35M | -4.65M | -4.77M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 7.22M | 11.04M | 13.63M | 17.42M | 21.10M |
| 权益乘数 | 2.10 | 1.69 | 1.42 | 1.39 | 1.26 |
| 每股净资产 | 0.3062 | 0.5806 | 0.8684 | 1.16 | 1.56 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 6.32M | 10.12M | 12.36M | 15.90M | 19.72M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 84890.00 | 107470.00 | 129067.00 | 182764.00 | 236221.00 |
| 净债务 | -6.26M | -10.04M | -12.27M | -15.76M | -19.53M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -3.77M | -2.79M | -4.57M | -3.94M | -4.38M |
| 投资现金流 | 4.25M | -1.70M | 5.93M | 3.59M | 3.24M |
| 融资现金流 | - | 526459.00 | 971781.00 | - | - |
| 自由现金流 | -2.88M | -1.26M | -3.13M | -2.26M | -2.67M |
| 现金流充裕率 | - | -279211300.00% | -823780.18% | - | -377533.22% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -1.00 | -555.00 | 0.0000 | -1159.00 |